FT218

sodium oxybate extended-release · Avadel Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FT218, covering 2025-10-02 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ) [Phase 3]